Authors:
Nakamura, R
Bahceci, E
Read, EJ
Leitman, SF
Carter, CS
Childs, R
Dunbar, CE
Gress, R
Altemus, R
Young, NS
Barrett, AJ
Citation: R. Nakamura et al., Transplant dose of CD34(+) and CD3(+) cells predicts outcome in patients with haematological malignancies undergoing T cell-depleted peripheral bloodstem cell transplants with delayed donor lymphocyte add-back, BR J HAEM, 115(1), 2001, pp. 95-104
Authors:
Childs, R
Chernoff, A
Contentin, N
Bahceci, E
Schrump, D
Leitman, S
Read, EJ
Tisdale, J
Dunbar, C
Linehan, WM
Young, NS
Barrett, AJ
Clave, E
Epperson, D
Mayo, V
Citation: R. Childs et al., Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation, N ENG J MED, 343(11), 2000, pp. 750-758
Authors:
Bahceci, E
Read, EJ
Leitman, S
Childs, R
Dunbar, C
Young, NS
Barrett, AJ
Citation: E. Bahceci et al., CD34+cell dose predicts relapse and survival after T-cell-depleted HLA-identical haematopoietic stem cell transplantation (HSCT) for haematological malignancies, BR J HAEM, 108(2), 2000, pp. 408-414
Authors:
Childs, R
Epperson, D
Bahceci, E
Clave, E
Barrett, J
Citation: R. Childs et al., Molecular remission of chronic myeloid leukaemia following a non-myeloablative allogeneic peripheral blood stem cell transplant: in vivo and in vitroevidence for a graft-versus-leukaemia effect, BR J HAEM, 107(2), 1999, pp. 396-400
Citation: N. Esen et E. Bahceci, Investigation of the cell mediated immune deficiency in rats with protein energy malnutrition, MED SCI RES, 26(11), 1998, pp. 763-766